Procefta-T 1.125Gm Inj Substitute
by Others
by Others
by AYUR
by Others
by Others
by Others
by Others
by AYUR
by Others
Composition:
CEFTAZIDIME-1000MG + TAZOBACTAM-125MG
Uses:
Procefta-T 1.125Gm Inj is used in the treatment of serious bacterial infections, including those caused by resistant organisms in hospital settings. The detailed uses of Procefta-T 1.125Gm Inj are as follows:<br/>• Treats respiratory infections: Procefta-T 1.125Gm Inj is effective in managing severe pneumonia, including hospital-acquired cases.<br/>• Manages urinary tract infections: Procefta-T 1.125Gm Inj is used for complicated UTIs, especially those involving resistant bacterial strains.<br/>• Controls skin and soft tissue infections: Procefta-T 1.125Gm Inj is indicated for cellulitis, infected wounds, and abscesses.<br/>• Treats intra-abdominal infections: Procefta-T 1.125Gm Inj is useful in the treatment of serious abdominal infections such as peritonitis.<br/>• Effective against hospital-acquired infections: Procefta-T 1.125Gm Inj acts against multidrug-resistant bacteria, including ESBL-producing organisms commonly found in hospital settings.<br/>• Enhances antibacterial action: Procefta-T 1.125Gm Inj provides a synergistic effect by inhibiting bacterial enzymes that break down antibiotics, thereby enhancing overall antibacterial activity against a wide range of gram-positive and gram-negative organisms.<br/>
Medicinal Benefits:
Procefta-T 1.125Gm Inj contains Ceftazidime and Tazobactam. Ceftazidime works by interfering with the production of the bacterial cell wall (a protective covering required for survival). Tazobactam reduces bacterial resistance and increases the action of Ceftazidime against bacteria. Together, they aid in the treatment of bacterial infections, including serious, life-threatening infections due to gram-positive bacteria.
Procefta-T 1.125Gm Inj is used to treat Bacterial infections.
Ceftazidime and Tazobactam are both present in Procefta-T 1.125Gm Inj. Ceftazidime works by preventing the production of the bacterial cell wall (a protective covering required for survival). Tazobactam reduces bacterial resistance while increasing the efficacy of Ceftazidime against bacteria. Together, Procefta-T 1.125Gm Inj aids in the treatment of bacterial illnesses.
Procefta-T 1.125Gm Inj may Increase liver enzymes. Therefore, if you are about to undergo any laboratory tests, inform your doctor or lab technician that you are taking Procefta-T 1.125Gm Inj.
Procefta-T 1.125Gm Inj may cause diarrhoea as a common side effect. However, if the condition persists or worsens, consult a doctor immediately.
If you are being treated with Procefta-T 1.125Gm Inj or have been treated within the last three days, you should talk to your doctor before taking the vaccine. Antibiotics like Procefta-T 1.125Gm Inj can reduce the vaccine's activity.
Procefta-T 1.125Gm Inj usually begins to work shortly after you start taking it. However, it may take a few days to eliminate all harmful bacteria and improve your symptoms.
If you do not get better after using Procefta-T 1.125Gm Inj, reach out to your doctor immediately. They might re-evaluate your condition, investigate potential issues, and modify your treatment accordingly.
Procefta-T 1.125Gm Inj causes side effects such as headache, dizziness, nausea, vomiting, diarrhoea, abdominal pain, muscle spasm, and elevated liver enzymes. Contact a doctor if these side effects persist for longer durations.